Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002064832-26-000139
Filing Date
2026-03-13
Accepted
2026-03-13 16:15:36
Documents
1
Period of Report
2026-03-11

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3890
  Complete submission text file 0002064832-26-000139.txt   5302
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2999 OLYMPUS BOULEVARD SUITE 500 DALLAS TX 75019
Business Address
FOLETTA MARK G (Reporting) CIK: 0001236389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 26752652